Trial Profile
Effects on re-endothelialisation with Bydureon treatment add on to Insulin versus Insulin alone, both in combination with Metformin in type 2 diabetic subjects (Rebuild Study)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2023
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Insulin aspart; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms Rebuild
- 19 Apr 2023 Status changed from recruiting to completed.
- 04 Sep 2019 Planned End Date changed from 1 Dec 2019 to 1 Dec 2021.
- 04 Sep 2019 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2021.